Middle East Pharmaceutical Industries Co.

Last Updated:
  • 59.00 SAR
  • 1.15
  • 1.99%
شركة الشرق الأوسط للصناعات الدوائية
أفالون فارما
Symbol : 4016
ISIN : SA160G51UO10
Day Range : -
Turnover Ratio : 0.55
Market : Saudi Exchange
Sector : Pharma, Biotech & Life Science
Latest Announcements
2026-05-14 05:28:00.0The Securities Depository Center Company (Edaa) Announces Implementing a Corporate Action on Middle East Pharmaceutical Industries Co. Securities
2026-05-12 05:45:00.0The Saudi Exchange announces that the fluctuation limits for Middle East Pharmaceutical Industries Co. will be based on a share price of ^58.85
2026-05-12 05:30:00.0Middle East Pharmaceutical Industries Co. Announces the Results of the Extraordinary General Assembly’s Meeting Included the Approval of the Company’s Capital Increase. (First Meeting)
2026-05-06 05:17:00.0Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2026-03-31 (Three Months)
2026-04-21 12:46:00.0Correction announcement from Middle East Pharmaceutical Industries Co. in regards to the Details of the Electronic Voting Feature on the Agenda Items of the Extraordinary General Assembly.

Middle East Pharmaceutical Industries Co. Stock Overview

View Company Profile

Stock Summary

Last Price (SAR) 59.00
Prev. Close 57.850
Day Range 57.80 - 60.50
52WK range
Turnover (M SAR) 20.06
Volume (M) 0.34
Number of Trades 2,302
Market Cap (M SAR) 2,065.00
Change in Market Cap (M SAR)
VWAP (SAR) 0.00
EPS (TTM) --
EX-Dividend Date
Dividend
Dividend Yield (%)
Beta
30D Avg Volume
30D Avg Turnover(M SAR)
Outstanding Shares
Free Float Shares
Free Float %

Stock Performance

Stock Highlights

Highest Market Cap
Date of Highest Mkt. Cap
Lowest Market Cap
Date of Lowest Mkt. Cap
View Advanced Chart

Earnings Progress

Date Provider Title Category File
Date Provider Title Category File
  • No Upcoming Events

Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) named Ahmad Shaher Al Tabbaa as the board’s Chairman for the next...

Riyadh - Mubasher: The Capital Market Authority (CMA) approved the request of Middle East Pharmaceutical Industries Company (Avalon Pharma) to...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with...

Riyadh – Mubasher: The board members of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved dividends worth SAR 25 million...

Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) is set to disburse cash dividends worth SAR 15 million,...